Fmoc-L-aspartic acid β-cyclohexyl ester is a protected, esterified amino acid derivative in which L-aspartic acid is modified at the β-carboxyl position to form a cyclohexyl ester while the α-amino group is protected as an Fmoc carbamate. The molecule contains the Fmoc-protected nitrogen, a free α-carboxyl group, and a β-COO-cyclohexyl functionality that alters polarity and provides an ester handle for controlled chemoselective transformations. In peptide chemistry and related synthesis, this protected amino acid ester is used as a building block that supports stepwise incorporation of the aspartate residue under conditions compatible with Fmoc-based protection while the β-ester group can be carried through coupling and later manipulated to access aspartate-derived side-chain functionality.
CAT No: CP00423
CAS No:130304-80-2
Synonyms/Alias:Fmoc-Asp(OcHex)-OH;130304-80-2;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(cyclohexyloxy)-4-oxobutanoicacid;Fmoc-Asp(OcHx)-OH;AmbotzFAA1705;PubChem18985;CTK8B7909;MolPort-003-981-641;ZINC2508186;ANW-58917;CF-174;AKOS015922865;AKOS016002008;RTR-004133;VA50284;Fmoc-L-asparticacid4-cyclohexylester;AJ-36267;AK-57354;AN-32342;AB0088944;A7861;FT-0643126;ST24035794;(2S)-4-(cyclohexoxy)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxo-butanoicacid
Fmoc-L-aspartic acid β-cyclohexyl ester is an Fmoc-protected L-aspartic acid derivative in which the side-chain carboxyl group is esterified with a cyclohexyl group, while the α-amino functionality is masked as an N-(9H-fluoren-9-ylmethoxycarbonyl) carbamate. The molecule therefore presents a stable, base-compatible N-protecting group for stepwise peptide assembly alongside a stereodefined chiral α-center characteristic of L-aspartate chemistry. The β-carboxylate functionality is present as a cyclohexyl ester, enabling controlled deprotection or transformation into an aspartate side-chain carboxylic acid during downstream synthesis. The combination of an aromatic Fmoc chromophore, a cyclohexyl ester, and the aspartate backbone supports predictable reactivity patterns in protected amino acid synthesis, peptide coupling, and subsequent functional group interconversion.
1. Peptide Synthesis
Fmoc-L-aspartic acid β-cyclohexyl ester is used as a protected aspartate building block for solid-phase peptide synthesis and solution-phase peptide coupling where Fmoc removal and reinstallation are compatible with standard orthogonal protection logic. The Fmoc carbamate on the α-amine supports iterative N-terminal deprotection, while the β-cyclohexyl ester limits side-chain acid reactivity during coupling steps. The aspartate backbone provides a carboxyl-derived handle that can be converted to the free β-carboxylic acid after peptide assembly, enabling formation of native or modified aspartyl motifs in peptides and peptide fragments. The cyclohexyl ester can serve as a controlled protection strategy for side-chain carboxyl chemistry, supporting downstream cyclization, salt formation, or further derivatization of the aspartate residue in peptide analog workflows.
2. Side-Chain Functionalization
Fmoc-L-aspartic acid β-cyclohexyl ester is suitable for chemical biology and medicinal chemistry programs that require deliberate side-chain modification of aspartate residues while maintaining peptide synthesis compatibility. The β-cyclohexyl ester acts as a protected carboxyl group that can be selectively unmasked or transformed to generate aspartate-derived electrophiles or nucleophile-bearing intermediates for conjugation chemistry. The presence of the Fmoc group enables controlled handling during synthetic sequences, allowing the compound to be incorporated into longer constructs before side-chain conversion. The resulting aspartate side-chain functionality can be applied to generate carboxylate salts, amide linkages, or carboxyl-derived derivatives used in structure-activity relationship studies of peptide-based scaffolds and peptidomimetics.
3. Chiral Building Block Synthesis
Fmoc-L-aspartic acid β-cyclohexyl ester functions as a stereodefined chiral amino acid intermediate for asymmetric and stereospecific synthetic routes that rely on L-aspartate configuration. The fixed stereochemistry at the α-carbon supports predictable incorporation into peptide frameworks and downstream derivatization without scrambling of stereochemical information. The Fmoc-protected α-amine provides a stable, isolable form that can be carried through multi-step synthesis as an amino acid ester with controlled functional group exposure. The β-cyclohexyl ester further supports stepwise transformations, enabling preparation of aspartate-containing intermediates for fine chemical synthesis and for generating defined stereochemical variants used in mechanistic studies of amino acid and peptide reactivity.
4. Bioconjugation Chemistry
Fmoc-L-aspartic acid β-cyclohexyl ester supports bioconjugation workflows that require aspartate-derived linkers or peptide-conjugate segments with controlled carboxyl functionality. The protected β-carboxyl group can be carried through peptide assembly or fragment synthesis, then converted to a free carboxylic acid for subsequent coupling to amines, hydrazides, or other nucleophiles depending on the chosen conjugation strategy. The Fmoc handle provides a practical protection/deprotection element for generating defined N-termini on peptide conjugates, which can influence conjugate solubility and labeling consistency. The aspartate residue contributes a polar, anionic functional motif after deprotection, enabling construction of conjugates used in chemical biology research, biomolecule labeling, and analytical reference material preparation.
5. Pharmaceutical Manufacturing Intermediates
Fmoc-L-aspartic acid β-cyclohexyl ester is applicable as a process chemistry intermediate for manufacturing peptide intermediates and protected amino acid feedstocks used in industrial peptide production. The Fmoc carbamate and cyclohexyl ester protection pattern supports robust handling through protection, coupling, and deprotection sequences typical of scalable peptide synthesis. The compound's defined functional group set enables controlled release of the β-carboxylic acid in downstream steps, supporting preparation of aspartate-containing drug-like peptide fragments and peptidomimetic building blocks. The aromatic Fmoc group can also facilitate monitoring and purification during manufacturing development, while the protected ester ensures side-chain compatibility with repeated coupling cycles in industrial settings.
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.